Appetite For Korean Biotechs Turns Sour, Voronoi Withdraws IPO

Bioventure Floats Drop In 1Q

 
• By Jung Won Shin

Weak broader stock market sentiment, topped with negative biotech industry news, weighs on Korean bioventure IPOs in the first quarter, with unicorn Voronoi withdrawing its IPO plan. But VC financing in the sector remains steady.

disappointment
Korea Exchange Increasingly Turns Down Bioventure IPO Approvals • Source: Alamy

More from South Korea

More from Focus On Asia